These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates. Tijerina M; Kopecková P; Kopecek J Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851 [TBL] [Abstract][Full Text] [Related]
4. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Omelyanenko V; Gentry C; Kopecková P; Kopecek J Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663 [TBL] [Abstract][Full Text] [Related]
5. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588 [TBL] [Abstract][Full Text] [Related]
6. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728 [TBL] [Abstract][Full Text] [Related]
9. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation. Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189 [TBL] [Abstract][Full Text] [Related]
10. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells. Tijerina M; Kopecková P; Kopecek J Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627 [TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics. Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676 [TBL] [Abstract][Full Text] [Related]
12. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Tijerina M; Fowers KD; Kopecková P; Kopecek J Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494 [TBL] [Abstract][Full Text] [Related]
13. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. Line BR; Mitra A; Nan A; Ghandehari H J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540 [TBL] [Abstract][Full Text] [Related]
14. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282 [TBL] [Abstract][Full Text] [Related]
15. Polymerizable Fab' antibody fragments for targeting of anticancer drugs. Lu ZR; Kopecková P; Kopecek J Nat Biotechnol; 1999 Nov; 17(11):1101-4. PubMed ID: 10545917 [TBL] [Abstract][Full Text] [Related]
16. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. Shiah JJ; Sun Y; Peterson CM; Kopecek J J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167 [TBL] [Abstract][Full Text] [Related]
18. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates. Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting. Li L; Yang Q; Zhou Z; Zhong J; Huang Y Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960 [TBL] [Abstract][Full Text] [Related]
20. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma. Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]